Teradyne (TER) Revenue — Quarter Ended Mar 29, 2026
Revenue increased sharply in the current quarter. The growth rate accelerated compared with the prior quarter and was substantially higher than the same quarter last year.
Key takeaway
Quarter ended Mar 29, 2026 · FY2026 Q1
Revenue increased sharply in the current quarter. The growth rate accelerated compared with the prior quarter and was substantially higher than the same quarter last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
+18.4%
Change from the immediately preceding quarter.
Year-over-year
+87.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 29, 2025 | $651.8M | -10.7% |
| Sep 28, 2025 | $769.2M | +4.3% |
| Dec 31, 2025 | $1.1B | +43.9% |
| Mar 29, 2026 | $1.3B | +87.0% |
Revenue performance
Reported revenue rose from the immediately preceding quarter, continuing an upward trend. The year-over-year comparison also showed a strong increase.
Quarterly comparison
Compared with the prior quarter, revenue improved. Versus the same quarter one year earlier, revenue was significantly higher.
What to watch
The filing context does not provide specific risk factors or management discussion beyond standard headings.